Gencor Industries Company Profile (NASDAQ:GENC)

About Gencor Industries

Gencor Industries logoGencor Industries, Inc. is a manufacturer of heavy machinery used in the production of highway construction materials, synthetic fuels and environmental control equipment. The Company designs, manufactures and sells machinery and related equipment used primarily for the production of asphalt and highway construction materials. Its geographical segments are United States and Other. The Company's principal products include asphalt plants, combustion systems and fluid heat transfer systems. It also manufactures related asphalt plant equipment, including hot mix storage silos, fabric filtration systems, cold feed bins and other plant components. The Company also manufactures soil remediation machinery, as well as combustion systems for rotary dryers, kilns, fume and liquid incinerators and fuel heaters. Its General Combustion subsidiary also manufactures the Hy-Way heat and Beverley lines of thermal fluid heat transfer systems and specialty storage tanks for an array of industry uses.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Farm & Construction Machinery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GENC
  • CUSIP:
Key Metrics:
  • Previous Close: $14.45
  • 50 Day Moving Average: $15.35
  • 200 Day Moving Average: $13.49
  • 52-Week Range: $14,376,000.00 - $8.67
  • Trailing P/E Ratio: 30.74
  • Foreward P/E Ratio: 36.13
  • P/E Growth: 0.00
  • Market Cap: $207.73M
  • Outstanding Shares: 14,376,000
  • Beta: 0.6
Profitability:
  • Net Margins: 9.38%
  • Return on Equity: 5.72%
  • Return on Assets: 5.28%
Debt:
  • Current Ratio: 10.94%
  • Quick Ratio: 9.87%
Additional Links:
Companies Related to Gencor Industries:

Analyst Ratings

Consensus Ratings for Gencor Industries (NASDAQ:GENC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Gencor Industries (NASDAQ:GENC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Gencor Industries (NASDAQ:GENC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017        
12/9/2014$0.06($0.06)ViewN/AView Earnings Details
8/5/2014$0.14$0.17ViewN/AView Earnings Details
2/7/2014Q1 14$0.05ViewN/AView Earnings Details
12/13/2013Q4$0.24ViewN/AView Earnings Details
2/11/2013Q1 2013($0.10)$6.90 million$4.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Gencor Industries (NASDAQ:GENC)
Current Year EPS Consensus Estimate: $0.34 EPS
Next Year EPS Consensus Estimate: $0.40 EPS

Dividends

Dividend History for Gencor Industries (NASDAQ:GENC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Gencor Industries (NASDAQ:GENC)
Insider Ownership Percentage: 31.82%
Institutional Ownership Percentage: 30.42%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/11/2017Sherry HoutkinMajor ShareholderSell20,000$15.77$315,400.00View SEC Filing  
1/9/2017Sherry HoutkinMajor ShareholderSell27,079$15.82$428,389.78View SEC Filing  
1/5/2017Sherry HoutkinMajor ShareholderSell10,000$15.60$156,000.00View SEC Filing  
12/28/2016Sherry HoutkinMajor ShareholderSell900$15.56$14,004.00View SEC Filing  
12/22/2016Sherry HoutkinMajor ShareholderSell11,401$15.60$177,855.60View SEC Filing  
12/20/2016Sherry HoutkinMajor ShareholderSell8,986$15.43$138,653.98View SEC Filing  
12/15/2016Sherry HoutkinMajor ShareholderSell3,831$15.92$60,989.52View SEC Filing  
12/13/2016Sherry HoutkinMajor ShareholderSell1,167$15.94$18,601.98View SEC Filing  
12/12/2016Lawrence MaingotVPSell500$16.00$8,000.00View SEC Filing  
12/12/2016Sherry HoutkinMajor ShareholderSell16,339$15.49$253,091.11View SEC Filing  
12/9/2016Dennis Bryan HuntInsiderSell14,750$15.45$227,887.50View SEC Filing  
12/7/2016Lawrence MaingotVPSell2,500$15.65$39,125.00View SEC Filing  
12/6/2016Sherry HoutkinMajor ShareholderSell18,727$15.55$291,204.85View SEC Filing  
12/2/2016Sherry HoutkinMajor ShareholderSell25,000$15.64$391,000.00View SEC Filing  
12/1/2016Sherry HoutkinMajor ShareholderSell5,000$14.17$70,850.00View SEC Filing  
11/29/2016Sherry HoutkinMajor ShareholderSell814$14.22$11,575.08View SEC Filing  
11/23/2016Sherry HoutkinMajor ShareholderSell3,101$14.81$45,925.81View SEC Filing  
11/22/2016Sherry HoutkinMajor ShareholderSell10,000$14.93$149,300.00View SEC Filing  
11/18/2016Sherry HoutkinMajor ShareholderSell2,390$14.79$35,348.10View SEC Filing  
8/29/2016Lawrence MaingotVPSell1,500$12.00$18,000.00View SEC Filing  
8/17/2016Eric E MellenCFOBuy10,000$10.75$107,500.00View SEC Filing  
7/27/2016Sherry HoutkinMajor ShareholderSell4,718$17.91$84,499.38View SEC Filing  
7/26/2016Sherry HoutkinMajor ShareholderSell7,000$17.31$121,170.00View SEC Filing  
7/22/2016Sherry HoutkinMajor ShareholderSell2,000$16.88$33,760.00View SEC Filing  
7/21/2016Sherry HoutkinMajor ShareholderSell10,000$16.85$168,500.00View SEC Filing  
7/19/2016Sherry HoutkinMajor ShareholderSell6,000$16.87$101,220.00View SEC Filing  
7/15/2016Sherry HoutkinMajor ShareholderSell13,541$16.74$226,676.34View SEC Filing  
7/13/2016Sherry HoutkinMajor ShareholderSell15,000$16.00$240,000.00View SEC Filing  
7/12/2016Sherry HoutkinMajor ShareholderSell5,000$15.51$77,550.00View SEC Filing  
7/11/2016Sherry HoutkinMajor ShareholderSell10,251$15.26$156,430.26View SEC Filing  
7/7/2016Sherry HoutkinMajor ShareholderSell11,890$15.07$179,182.30View SEC Filing  
6/7/2016Marc G ElliottPresidentSell15,000$14.91$223,650.00View SEC Filing  
6/3/2016Marc G ElliottPresidentSell2,000$14.74$29,480.00View SEC Filing  
5/16/2016Marc G ElliottPresidentSell24,000$14.86$356,640.00View SEC Filing  
3/3/2016David AirDirectorSell5,000$13.40$67,000.00View SEC Filing  
3/2/2016Sherry HoutkinMajor ShareholderSell10,000$13.38$133,800.00View SEC Filing  
3/1/2016Sherry HoutkinMajor ShareholderSell20,000$13.54$270,800.00View SEC Filing  
2/26/2016Sherry HoutkinMajor ShareholderSell50,000$13.11$655,500.00View SEC Filing  
2/17/2016Marc G. ElliottPresidentSell9,140$12.68$115,895.20View SEC Filing  
12/15/2015Marc G. ElliottPresidentSell19,044$12.74$242,620.56View SEC Filing  
10/6/2015Sherry HoutkinMajor ShareholderSell80,000$9.26$740,800.00View SEC Filing  
5/6/2015Sherry HoutkinMajor ShareholderSell70,000$9.20$644,000.00View SEC Filing  
12/8/2014Sherry HoutkinMajor ShareholderSell2,948$9.72$28,654.56View SEC Filing  
12/2/2014Sherry HoutkinMajor ShareholderSell5,000$9.93$49,650.00View SEC Filing  
11/25/2014Sherry HoutkinMajor ShareholderSell200,000$9.25$1,850,000.00View SEC Filing  
9/2/2014Sherry HoutkinMajor ShareholderSell5,000$10.18$50,900.00View SEC Filing  
8/26/2014Sherry HoutkinMajor ShareholderSell5,346$10.23$54,689.58View SEC Filing  
8/25/2014Sherry HoutkinMajor ShareholderSell344$10.20$3,508.80View SEC Filing  
8/21/2014Sherry HoutkinMajor ShareholderSell4,984$10.18$50,737.12View SEC Filing  
8/20/2014Sherry HoutkinMajor ShareholderSell2,200$10.16$22,352.00View SEC Filing  
8/19/2014Sherry HoutkinMajor ShareholderSell1,208$10.20$12,321.60View SEC Filing  
3/11/2014Jeanne M LyonsInsiderSell1,500$10.93$16,395.00View SEC Filing  
2/20/2014Jeanne M LyonsInsiderSell2,000$10.97$21,940.00View SEC Filing  
2/19/2014Eric E MellenCFOSell11,051$11.07$122,334.57View SEC Filing  
10/14/2013Sherry HoutkinMajor ShareholderSell80,086$8.80$704,756.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Gencor Industries (NASDAQ:GENC)
DateHeadline
4-traders.com logoFirsTime Design Limited : Announces Fourth Quarter 2016 Results (NASDAQ:GENC)
www.4-traders.com - February 23 at 10:23 PM
biz.yahoo.com logoGENCOR INDUSTRIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:GENC)
biz.yahoo.com - February 23 at 5:22 PM
biz.yahoo.com logoGENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:GENC)
biz.yahoo.com - February 8 at 4:46 AM
finance.yahoo.com logo8:02 am Gencor Industries reports Q1 EPS of $0.10 vs. $0.11 in prior year; revs rose $19% YoY to $15.8 mln - no estimates (NASDAQ:GENC)
finance.yahoo.com - February 5 at 5:12 PM
nasdaq.com logoGencor Releases First Quarter Fiscal 2017 Results (NASDAQ:GENC)
www.nasdaq.com - February 3 at 5:50 PM
nasdaq.com logoGencor Releases First Quarter Fiscal 2017 Results (NASDAQ:GENC)
www.nasdaq.com - February 3 at 5:50 PM
sg.finance.yahoo.com logoGencor posts 1Q profit (NASDAQ:GENC)
sg.finance.yahoo.com - February 3 at 5:50 PM
streetinsider.com logoForm 4/A GENCOR INDUSTRIES INC For: Jan 09 Filed by: Houtkin Sherry (NASDAQ:GENC)
www.streetinsider.com - January 14 at 5:26 PM
marketexclusive.com logoInsider Trading Activity Gencor Industries Inc. (NASDAQ:GENC) – major shareholder Sold 10,000 shares of Stock (NASDAQ:GENC)
marketexclusive.com - January 9 at 3:10 AM
publicnow.com logoGenmab Achieves USD 25 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen (NASDAQ:GENC)
www.publicnow.com - January 6 at 5:55 PM
publicnow.com logoGenmab Announces Studies of Daratumumab (DARZALEX®) in Combination with Nivolumab in Solid Tumors and Multiple Myeloma (NASDAQ:GENC)
www.publicnow.com - January 5 at 6:20 PM
marketexclusive.com logoInsider Trading Activity Gencor Industries Inc. (NASDAQ:GENC) – major shareholder Sold 11,401 shares of Stock (NASDAQ:GENC)
marketexclusive.com - December 28 at 11:21 AM
us.rd.yahoo.com logoPost Earnings Coverage as Joy Global Sales Tumbled 24%; Loss Narrowed (NASDAQ:GENC)
us.rd.yahoo.com - December 21 at 6:17 PM
capitalcube.com logoETFs with exposure to Gencor Industries, Inc. : December 19, 2016 (NASDAQ:GENC)
www.capitalcube.com - December 20 at 10:36 AM
publicnow.com logoGenmab Announces Submission of Regulatory Application for Daratumumab in Relapsed/Refractory Multiple Myeloma in Japan and Updates Financial Guidance (NASDAQ:GENC)
www.publicnow.com - December 20 at 10:36 AM
insidermonkey.com logoIs KCAP Financial Inc (KCAP) A Good Stock to Buy? (NASDAQ:GENC)
www.insidermonkey.com - December 19 at 10:45 AM
4-traders.com logoGencor Industries DE : Sherry Houtkin Sells 25,000 Shares (NASDAQ:GENC)
www.4-traders.com - December 17 at 5:38 PM
News IconSenior Vice President, Sales of Gencor Industries Inc (NASDAQ:GENC), Hunt Dennis Bryan, sells 4,750 shares worth $73,720 (NASDAQ:GENC)
empowerednews.net - December 13 at 5:57 PM
4-traders.com logoGencor Industries DE : RELEASES FOURTH QUARTER AND FISCAL YEAR 2016 RESULTS (NASDAQ:GENC)
www.4-traders.com - December 12 at 5:35 PM
capitalcube.com logoETFs with exposure to Gencor Industries, Inc. : December 8, 2016 (NASDAQ:GENC)
www.capitalcube.com - December 8 at 6:02 PM
capitalcube.com logoGencor Industries, Inc. :GENC-US: Earnings Analysis: 2016 By the Numbers : December 7, 2016 (NASDAQ:GENC)
www.capitalcube.com - December 7 at 10:44 AM
streetinsider.com logoForm 4 GENCOR INDUSTRIES INC For: Dec 02 Filed by: Houtkin Sherry (NASDAQ:GENC)
www.streetinsider.com - December 5 at 5:58 PM
us.rd.yahoo.com logo8:06 am Gencor Industries swings to Q4 profit with rev up 79%; backlog up 131% Y/Y (NASDAQ:GENC)
us.rd.yahoo.com - December 2 at 8:25 PM
marketexclusive.com logoGENCOR INDUSTRIES, INC. (NASDAQ:GENC) Files An 8-K Results of Operations and Financial Condition (NASDAQ:GENC)
marketexclusive.com - December 2 at 3:24 PM
us.rd.yahoo.com logoGencor Releases Fourth Quarter and Fiscal Year 2016 Results (NASDAQ:GENC)
us.rd.yahoo.com - December 2 at 8:33 AM
sg.finance.yahoo.com logoGencor posts 4Q profit (NASDAQ:GENC)
sg.finance.yahoo.com - December 2 at 8:33 AM
publicnow.com logoGenmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) for Relapsed Multiple Myeloma and Updates Financial Guidance (NASDAQ:GENC)
www.publicnow.com - November 21 at 5:30 PM
finance.yahoo.com logoA Value Stock to Profit For Trump's Presidency (NASDAQ:GENC)
finance.yahoo.com - November 11 at 10:26 PM
publicnow.com logoGenmab Announces Phase III Study of Daratumumab in Combination with Carfilzomib in Multiple Myeloma (NASDAQ:GENC)
www.publicnow.com - November 10 at 8:38 AM
publicnow.com logoGenmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance (NASDAQ:GENC)
www.publicnow.com - November 2 at 5:25 PM
publicnow.com logoU.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma (NASDAQ:GENC)
www.publicnow.com - October 8 at 9:48 AM
publicnow.com logoData from Phase III POLLUX Study of Daratumumab Published in The New England Journal of Medicine (NASDAQ:GENC)
www.publicnow.com - October 6 at 8:49 AM
globenewswire.com logoGencor Announces Chief Executive Officer Transition (NASDAQ:GENC)
globenewswire.com - September 30 at 10:17 AM
bizjournals.com logoGencor announces CEO transition (NASDAQ:GENC)
www.bizjournals.com - September 30 at 10:17 AM
biz.yahoo.com logoGENCOR INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financ (NASDAQ:GENC)
biz.yahoo.com - September 30 at 10:17 AM
publicnow.com logoGenmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL (NASDAQ:GENC)
www.publicnow.com - August 31 at 9:54 AM
publicnow.com logoData from Phase III CASTOR Study of Daratumumab Published in The New England Journal of Medicine (NASDAQ:GENC)
www.publicnow.com - August 25 at 10:12 AM
publicnow.com logoGenmab Announces European Regulatory Submission for Daratumumab in Relapsed Multiple Myeloma (NASDAQ:GENC)
www.publicnow.com - August 23 at 9:32 AM
publicnow.com logoArticles of Association for Genmab A/S (NASDAQ:GENC)
www.publicnow.com - August 18 at 5:13 PM
publicnow.com logoTransactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons (NASDAQ:GENC)
www.publicnow.com - August 17 at 5:26 PM
finance.yahoo.com logoGENCOR INDUSTRIES INC Financials (NASDAQ:GENC)
finance.yahoo.com - August 17 at 5:26 PM
publicnow.com logoGenmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Relapsed Multiple Myeloma (NASDAQ:GENC)
www.publicnow.com - August 17 at 5:26 PM
capitalcube.com logoETF’s with exposure to Gencor Industries, Inc. : August 16, 2016 (NASDAQ:GENC)
www.capitalcube.com - August 16 at 5:21 PM
capitalcube.com logoGencor Industries, Inc. :GENC-US: Earnings Analysis: Q3, 2016 By the Numbers : August 12, 2016 (NASDAQ:GENC)
www.capitalcube.com - August 12 at 5:15 PM
publicnow.com logoGenmab Enters Commercial License Agreement with Gilead for DuoBody® Technology (NASDAQ:GENC)
www.publicnow.com - August 10 at 5:26 PM
News IconGencor Sales Up 82.6% in 3Q (NASDAQ:GENC)
www.mdm.com - August 9 at 9:32 PM
nasdaq.com logoGencor Releases Third Quarter Fiscal 2016 Results (NASDAQ:GENC)
www.nasdaq.com - August 9 at 9:32 PM
sg.finance.yahoo.com logoGencor posts 3Q profit (NASDAQ:GENC)
sg.finance.yahoo.com - August 9 at 3:56 PM
publicnow.com logoGenmab Announces Financial Results for the First Half of 2016 and Improves 2016 Financial Guidance (NASDAQ:GENC)
www.publicnow.com - August 9 at 3:56 PM
publicnow.com logoGenmab Appoints Board Observer (NASDAQ:GENC)
www.publicnow.com - August 3 at 8:07 AM

Social

What is Gencor Industries' stock symbol?

Gencor Industries trades on the NASDAQ under the ticker symbol "GENC."

When will Gencor Industries announce their earnings?

Gencor Industries is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.

How do I buy Gencor Industries stock?

Shares of Gencor Industries can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Gencor Industries stock cost?

One share of Gencor Industries stock can currently be purchased for approximately $14.45.

Gencor Industries (NASDAQ:GENC) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Gencor Industries (NASDAQ:GENC)

Earnings History Chart

Earnings by Quarter for Gencor Industries (NASDAQ:GENC)

Dividend History Chart

Dividend Payments by Quarter for Gencor Industries (NASDAQ:GENC)

Last Updated on 2/27/2017 by MarketBeat.com Staff